Heron Therapeutics Inc Investor Relations Material

Heron Therapeutics, Inc. is a biotechnology company that engages in the development of treatments to address unmet patient needs. The company uses Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. Heron Therapeutics, Inc. offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant for preventing acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy.